Mon.Oct 21, 2024

article thumbnail

Efficacy of Immunization for Pediatric Health Outcomes, Antibiotic Use | IDWeek 2024

Drug Topics

Researchers explored the overall efficacy of various pediatric vaccines and their effects on antibiotic use, while also addressing vaccine hesitancy among parents.

article thumbnail

Embedding into the provider’s workflow is key to a specialty drug’s success

PharmaVoice

Providers struggle with time-consuming processes. Patients are waiting for therapy. Embedded EMR system solutions can streamline therapy initiation and improve outcomes.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Nonopioid Suzetrigine Demonstrates Positive Phase 3 Results for Acute Pain | ASA 2024

Drug Topics

Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.

386
386
article thumbnail

FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage

PharmaVoice

After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Rates of Opioid Use Disorder With Gabapentin, Benzodiazepine Coprescription Evaluated

Drug Topics

Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.

307
307
article thumbnail

Walking Together: How Pinksocks Are Inspiring Compassion and Connection in Cancer Care

Pharmacy Times

The story of pinksocks and the inspiring movement that they launched.

149
149

More Trending

article thumbnail

Dietary experts advise skipping guidelines on ultra-processed foods — for now

STAT

If you were hoping to see where ultra-processed foods might fit in the next Dietary Guidelines for Americans, hold that thought. Scientific experts tasked with advising federal officials drafting the 2025-2030 Dietary Guidelines for Americans said the data were far too limited to draw conclusions. Meeting Monday, the first of two days of presentations, they discussed research findings to inform a report to the Department of Health and Human Services and the Department of Agriculture.

145
145
article thumbnail

Examining Race-Based Disparities in Access to Multimodal Analgesia

Drug Topics

Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.

216
216
article thumbnail

STAT+: Former FDA lawyers join tobacco industry in ‘epic’ fight against the agency

STAT

STAT is publishing this investigation in partnership with The Examination. Perham Gorji was a career government lawyer, helping to lead the Food and Drug Administration’s battle against tobacco and e-cigarettes.  He was there as the agency contemplated a ban on menthol cigarettes, and as vapes of all shapes and sizes flooded the market, hooking a new generation on nicotine.

FDA 143
article thumbnail

Education Resources Affect Pharmacy Pneumococcal Vaccination Conversations

Drug Topics

Pharmacist education can positively impact patient counseling around vaccinations in older adults.

Vaccines 216
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies 

STAT

Confounding data from a Pfizer clinical trial has rattled the field of gene therapy for Duchenne muscular dystrophy, raising more questions about the regulatory standard used to approve a treatment from Sarepta Therapeutics, and complicating plans for other companies hoping to develop next-generation products.  Scientifically, Pfizer’s gene therapy did what it was supposed to do.

138
138
article thumbnail

Pharmacy Screening Can Identify Depression in Older Adults

Drug Topics

Normalizing conversations around mental health in older adult populations can improve outcomes.

216
216
article thumbnail

After shingles damaged her vision, this former eye surgeon looked for a way to keep it from happening to others

STAT

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next day, as she was pushing her hair back on that side of her head, she noticed a blister near the hairline. She knew immediately what it was: shingles.  At the time, in 2008, Cohen was director of the Cornea Service at Wills Eye Hospital in Philadelphia.

Hospitals 135
article thumbnail

Q&A: What Pharmacists Need to Know about Onyda XR for the Treatment of ADHD

Drug Topics

A conversation with Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at Texas Tech University School of Medicine.

190
190
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

A telling chart shows how health insurers found a way to boost profits by limiting care for seniors

STAT

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine.  Sign up  to get it in your inbox every Monday. The ‘#1 PRIORITY’ The emails from inside a physician practice owned by UnitedHealth Group sounded cheery, but were all business.

Insurance 134
article thumbnail

How AI can manage the risks and costs of postmarketing requirements

PharmaVoice

PMRs are not new but drug developers can use AI to predict risk and manage costs earlier in studies.

130
130
article thumbnail

Philadelphia-area health systems end use of four race-based algorithms to guide care

STAT

A coalition of 12 Philadelphia-area health systems announced Monday that its members have abandoned the use of race adjustments in four clinical tools commonly used to guide care, a move that health leaders say will improve treatment and prevent delays in diagnosis for Black, Hispanic, and Asian patients.  The decision marks one of the largest and broadest efforts to date to remove race from widely used clinical algorithms.

Hospitals 131
article thumbnail

Amazon One Medical, Cleveland Clinic to open primary care clinics in Northeast Ohio

Fierce Healthcare

Academic health system Cleveland Clinic is teaming up with an industry disruptor to expand primary care services in Northeast Ohio. | Academic health system Cleveland Clinic is teaming up with an industry disruptor to expand primary care services in Northeast Ohio.

128
128
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

STAT+: Behind CVS CEO’s ouster, a question: Do a pharmacy and a health insurer make sense together?

STAT

Does it make sense for a chain of drug stores to own a major health insurance company? That has been the existential question for CVS Health for six years, since its $70 billion acquisition of the massive insurer Aetna. The biggest pharmacy chain in the U.S. had already been moving beyond retail since its 2007 deal for pharmacy benefit manager Caremark.

Insurance 129
article thumbnail

American Pharmacists Month: Frank Kessler Reflects on Decades of Work in Community Pharmacy

Pharmacy Times

A dedicated community pharmacist for over 40 years, Kessler has witnessed immense change and innovation throughout his career.

article thumbnail

Gilead, MSD say HIV combo could be weekly, oral HIV drug

pharmaphorum

An antiretroviral combination developed by Gilead and MSD suppressed HIV with a single weekly oral dose in a phase 2 trial reported at IDWeek 2024

122
122
article thumbnail

FDA Approves Companion Diagnostic To Identify Patients With Grade 2 IDH-Mutant Glioma Eligible for Vorasidenib

Pharmacy Times

The diagnostic test is a companion to vorasidenib, an isocitrate dehydrogenase inhibitor that received FDA approval this past summer.

FDA 123
article thumbnail

Using AI, images are fueling a new boom in cell biology

STAT

Compared to molecular techniques to study single cells, images feel a little like “old school biology,” says Anne Carpenter, an artificial intelligence and cell biology researcher at the Broad Institute. Yet  images are a gold mine that can yield information as rich as the genome — once you learn how to extract it.  Carpenter is using AI and other computational methods to do exactly that, helping to propel an AI-driven boom in cell biology and medicine over the pas

121
121
article thumbnail

HLTH24: GE Healthcare unveils iPhone-like AI platform, CareIntellect

Fierce Healthcare

LAS VEGAS – GE Healthcare unveiled its new generative AI platform, CareIntellect, on stage at HLTH 2024 on Monday. The first application available on the platform is for oncology. | GE Healthcare aims to make integrating generative AI into healthcare delivery less clunky through its new CareIntellect platform, which will eventually host a range of clinical and operational AI solutions.

121
121
article thumbnail

Opinion: The inadequate language of pregnancy loss

STAT

I have lost babies. Well, I didn’t lose them per se. They haven’t been misplaced, like keys or something. To forgo the polite euphemisms, they died after 20 weeks.  I felt isolated, devastated, and like there wasn’t a vocabulary for what happened — clinically, emotionally, or legally.

119
119
article thumbnail

HLTH24 Day 2: Google Cloud, Recursion expand tech partnership; HealthEx raises $14M

Fierce Healthcare

LAS VEGAS—Recursion and Google Cloud have expanded their tech partnership to use cloud technologies to power Rcursion's drug discovery platform. | On the second day of HLTH, Recursion announced it was deepening its partnership with Google Cloud and HealthEx unveiled a $14 million funding round.

118
118
article thumbnail

PursueCare brings Pear addiction DTx apps back to life

pharmaphorum

Two digital therapeutics for addiction are available again through PursueCare, which acquired them from now-defunct Pear Tx last year

115
115
article thumbnail

HLTH24: Blue Shield of California, Salesforce join forces to streamline prior authorization

Fierce Healthcare

LAS VEGAS — Blue Shield of California and Salesforce are teaming up to simplify and streamline the prior authorization experience. | LAS VEGAS — Blue Shield of California and Salesforce are teaming up to simplify and streamline the prior authorization experience.

118
118
article thumbnail

Seaport docks $225m for its improved neuropsychiatry drugs

pharmaphorum

Seaport Therapeutics completes a $225m Series B to fund its improved therapies for depression and anxiety, just months after raising $100m on its debut

115
115
article thumbnail

Humana joins chorus of lawsuits over sinking star ratings

Fierce Healthcare

Humana, one the country’s largest Medicare Advantage organizations, is suing the Centers for Medicare & Medicaid Services over its 2025 star | Humana, one the country’s largest Medicare Advantage organizations, is suing the Centers for Medicare & Medicaid Services over its 2025 star ratings results.

115
115
article thumbnail

Morning Rounds: RFK fears, an ‘epic’ FDA fight, Marburg update

STAT

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.  Sign up here. Have you ever seen an award-winning journalist sing karaoke? After the Summit ended last week, a big group of STAT staffers belted and crooned together for hours and my heart has never been so full. It was all deeply off the record so I can’t tell you who sang what.

FDA 113
article thumbnail

US government proposes birth control, HIV preventive service protections

Fierce Healthcare

With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster protections around birth control and other preventive services. | The U.S. federal government is attempting to ease access to birth control products and HIV prevention drugs in a newly proposed rule.

114
114
article thumbnail

STAT+: Pharmalittle: We’re reading about ballooning 340B drug sales, Catalent reassuring customers, and more

STAT

Good morning, everyone, and welcome to another working week. We hope the weekend respite was refreshing and invigorating, because that oh-so familiar routine of online meetings, calls, and deadlines has predictably returned. To cope, we are firing up the coffee kettle in the Pharmalot cafeteria and brewing another cup of stimulation. Our choice today is the seasonal pumpkin spice.

Vaccines 111